Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-γ during β-cell destruction

Diabetes

Volumn 45, Issue 10, 1996, Pages 1350-1357

  Suarez Pinzon, Wilma ^a   Rajotte, Ray V ^a   Mosmann, Tim R ^a   Rabinovitch, Alex ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT FAILURE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREATITIS; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029764082     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.10.1350     Document Type: Article

References (38)

1. Castano L, Eisenbarth GS: Type-I diabetes: a chronic autoimmune disease of human, mouse and rat. Ann Rev Immunol 8:647-679, 1990
2. Rossini AA, Greiner DL, Friedman HP, Mordes JP: Immunopathogenesis of diabetes mellitus. Diabetes Rev 1:43-75, 1993
3. Bach JF: Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev 15:516-542, 1994
4. + T-cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140:52-58, 1988
5. Bedossa P, Bendelac A, Bach JF, Carnaud C: Syngeneic T-cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction. Eur J Immunol 19:1947-1951, 1989
6. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci USA 88:527-031, 1991
7. + T-cell clones derived from lymphocytes infiltrating the islets of NOD mice. Diabetes 41:998-1008, 1992
8. a donors. Diabetes 42:44-55, 1993
9. + T-cells are required for adoptive transfer of the BB rat diabetic syndrome. Diabetes 42:390-397, 1993
10. Held W, MacDonald HE, Weissman IL, Hess MW, Mueller C: Genes encoding tumor necrosis factor-α and granzyme A are expressed during developing of autoimmune diabetes. Proc Natl Acad Sci USA 87:2239-2243, 1990
11. Jiang Z, Woda BA: Cytokine gene expression in the islets of the diabetic BioBreeding/Worcester rat. J Immunol 146:2990-2994, 1991
12. Anderson JT, Cornelius JG, Jarpe AJ, Winter WE, Peck AB: Insulin-dependent diabetes in the NOD mouse model II. β-cell destruction in autoimmune diabetes is a Th2- and not a Th1-mediated event. Autoimmunity 15:113-122, 1993
13. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF: IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 154:4874-4882, 1994
14. Rabinovitch A, Sorensen O, Suarez-Pinzon WL, Power RF, Rajotte RV, Bleackley RC: Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and Interferon gamma mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia 37:833-837, 1994
15. Huang X, Hultgren B, Dybdal N, Stewart TA: Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity 1:469-478, 1994
16. Muir A, Peck A, Clare-Salzler M, Song Y-H, Cornelius J, Luchetta R, Krischer J, Maclaren N: Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J Clin Invest 95:628-634, 1995
17. Foulis AK, McGill M, Farquharson MA: Insulitis in type 1 (insulin-dependent) diabetes mellitus in man - macrophages, lymphocytes, and interferon-containing cells. J Pathol 165:97-103, 1991
18. Campbell IL, Kay TWH, Oxbrow L, Harrison LC: Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87:739-742, 1991
19. Shehadeh N, LaRosa F, Lafferty KJ: Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmunity 6:291-300, 1993
20. Rothe H, Faust A, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H: Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and Interferon-γ, but not of interleukin-4. Diabetologia 37:1154-1158, 1994
21. Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL: Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E. Am J Pathol 147:1193-1199, 1995
22. Wang T, Singh B, Warnock GL, Rajotte RV: Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 41:114-117, 1992
23. Sander B, Andersson J, Andersson U: Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev 119:65-93, 1991
24. Cher DJ, Mosmann TR: Two types of murine helper T cell clones: II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 138:3688-3694, 1987
25. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7:145-173, 1989
26. Henter JI, Soder O, Andersson U: Identification of individual tumor necrosis factor/cachectin-producing cells after lipopolysaccharide induction. Eur J Immunol 18:983-988, 1988
27. Rabinovitch A: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 43:613-621, 1994
28. + cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 45:71-78, 1996
29. + Th1 and Th2 T cells derived from the spleens of diabetic NOD mice. J Clin Invest 95:2979-2985, 1995
30. Katz JD, Benoist C, Mathis D: T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188, 1995
31. + T cell subset that inhibits this autoimmune potential. J Exp Med 177:627-636, 1993
32. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL: IL-4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in NOD mice. J Exp Med 178:87-99, 1993
33. Pennline KJ, Roque-Gaffney E, Monahan M: Recombinant human IL-10 (rHU IL-10) prevents the onset of diabetes in the nonobese diabetic (NOD) mouse. Clin Immunol Immunopathol 71:169-175, 1994
34. Rabinovitch A, Suarez-Pinzon, WL, Sorensen O, Bleackley RC, Power RF, Rajotte RV: Combined therapy with interleukin 4 and interleukin 10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Transplantation 60:368-374, 1995
35. Fitch FW, McKisic MD, Lancki DW, Gajewski TF: Differential regulation of murine T lymphocyte subsets. Ann Rev Immunol 11:29-48, 1993
36. + T-cells. Ann Rev Immunol 12:635-673, 1994
37. Moore KV, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin 10. Ann Rev Immunol 11:165-190, 1993
38. Farrar MA, Schreiber RD: The molecular cell biology of Interferon-γ and its receptor. Ann Rev Immunol 11:571-611, 1993